Recording of Equity-Method Investment Losses
First written in FY2023-Q1. . Latest entry: FY2026.
The whole theme swung hardest in 2023: 19 of 68 companies on the "Worse" side.
24 other companies' latest entry also says "Other".
- FY2026Loss on Investments Accounted for Using the Equity Method Decreased Year on YearAnnual report
「Ordinary income was ¥534 million, following the recognition of ¥243 million in non-operating income, including a ¥230 million foreign exchange gain, and non-operating expenses including ¥200 million in interest expense and a ¥58 million loss on investments accounted for using the equity method related to Changzhou Waston Ortho Medical Appliance Co., Limited, an equity-method affiliate.」
The loss on investments accounted for using the equity method related to the Chinese joint venture amounted to ¥58 million, down from ¥65 million in the previous fiscal year. - FY2026-H1Loss on investments accounted for using the equity method increased year on yearAnnual report
「Ordinary income was ¥130 million, down 80.4% year on year, following the recognition of ¥50 million in non-operating income, including a ¥42 million foreign exchange gain, and non-operating expenses including ¥91 million in interest expense and a ¥25 million loss on investments accounted for using the equity method for the Chinese joint venture Changzhou Waston Ortho Medical Appliance Co., Limited.」
The loss on investments accounted for using the equity method related to the Chinese joint venture amounted to ¥25 million, up from ¥17 million in the same period of the previous year. - FY2025-H1Loss on investments accounted for using the equity method decreased year on yearAnnual report
「Ordinary income was ¥664 million, up 5.1% year on year, following the recognition of ¥43 million in non-operating income, including a ¥37 million foreign exchange gain, and ¥47 million in non-operating expenses, including ¥24 million in interest expense and a ¥17 million loss on investments accounted for using the equity method for the Chinese joint venture Changzhou Waston Ortho Medical Appliance Co., Limited.」
The loss on investments accounted for using the equity method related to the Chinese joint venture amounted to ¥17 million, down from ¥31 million in the same period of the previous year. - FY2024Increase in share of loss of investments accounted for using the equity methodAnnual report
「Ordinary income was ¥1,842 million, down 9.8% from the previous consolidated fiscal year, after recording ¥213 million in non-operating income, including ¥190 million in foreign exchange gains, and ¥116 million in non-operating expenses, including a ¥65 million loss on investments accounted for under the equity method and ¥31 million in interest expense.」
The loss on investments accounted for using the equity method amounted to ¥65 million, up from ¥63 million in the previous year. - FY2024-Q3Cumulative loss on investments accounted for using the equity method increasedAnnual report
「Ordinary income was ¥1,225 million, down 20.6% year on year, following the recognition of ¥122 million in non-operating income, including a ¥102 million foreign exchange gain, and ¥80 million in non-operating expenses, including a ¥44 million loss on investments accounted for using the equity method and ¥22 million in interest expense.」
The loss on investments accounted for using the equity method increased from ¥31 million for the second quarter consolidated cumulative period to ¥44 million for the third quarter consolidated cumulative period. - FY2024-Q2Cumulative loss on investments accounted for using the equity method increasedAnnual report
「Ordinary income was ¥632 million, down 31.0% year on year, following the recognition of ¥69 million in non-operating income, including a ¥59 million foreign exchange gain, and ¥55 million in non-operating expenses, including a ¥31 million loss on investments accounted for using the equity method.」
The loss on investments accounted for using the equity method increased from ¥16 million in the first quarter to ¥31 million for the second quarter consolidated cumulative period. - FY2024-Q1¥16 million loss on investments accounted for using the equity method recognizedAnnual report
「Ordinary income was ¥337 million, down 30.2% year on year, following the recognition of ¥17 million in non-operating income, including a ¥10 million foreign exchange gain, and ¥26 million in non-operating expenses, including a ¥16 million loss on investments accounted for using the equity method.」
A ¥16 million loss on investments accounted for using the equity method was recognized as a non-operating expense in the first quarter consolidated cumulative period, up from ¥7.642 million in the same quarter of the previous year. - FY2023-Q3Increase in share of loss of investments accounted for using the equity methodAnnual report
「Ordinary income was ¥1,543 million, down 21.1% year on year, following the recognition of ¥104 million in non-operating income, including a ¥61 million foreign exchange gain and ¥15 million in tax refunds, and ¥72 million in non-operating expenses, including a ¥42 million loss on investments accounted for using the equity method.」
The loss on investments accounted for using the equity method amounted to ¥42 million, up from ¥26 million in the previous quarter's cumulative period. - FY2023-Q2Increase in share of loss of investments accounted for using the equity methodAnnual report
「Ordinary income was ¥916 million, down 12.1% year on year, following the recognition of ¥39 million in non-operating income, including ¥14 million in tax refunds and ¥13 million in insurance proceeds, and ¥49 million in non-operating expenses, including a ¥26 million loss on investments accounted for using the equity method.」
A ¥26 million loss on investments accounted for using the equity method was recognized, increasing from the cumulative ¥7.642 million reported for the previous quarter. - FY2023-Q1First statedAnnual report
「Loss on investments accounted for using the equity method - 7,642」
A ¥7.642 million loss on investments accounted for using the equity method was recognized as a non-operating expense in the first quarter consolidated cumulative period.